Revised SPCs: Kalydeco (ivacaftor) granules in sachet – all strengths
SPCs updated to include extension of licence, to include treatment of patients with cystic fibrosis, aged at least 4 months, weighing 5 kg to less than 25 kg, with revisions in various sections to reflect treatment of this age group.
Source:
electronic Medicines compendium